tPA gene therapy (Stanford)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NametPA gene therapy (Stanford)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionPlasminogen modulators
TargetsPlasminogen
Therapy Area/IndicationsPeripheral Vascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesStanford University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStanford University
Active IndicationsN/A
Inactive IndicationsPeripheral Vascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A